Abstract:Abstract Background and Aims Regenerating protein 1a (Reg 1a) is a secretory protein mostly produced by the pancreas. Serum levels of Reg 1a has been found increased in patients with diabetic nephropathy, which may be a potential indicator of renal dysfunction. Here, we investigated whether Reg 1a was associated with renal function in chronic kidney disease (CKD) and further to evaluate its predictive value of progress in renal dysfunction. Method Serum Reg 1a levels were measured by a double antibody sandwich ELISA enzyme-linked immunosorbent assay. Demographics information and clinical biochemical parameters such as blood urea nitrogen (BUN), serum creatinine (Scr), uric acid (UA) and urinary albumin-to-creatinine ratio (UACR) were collected. Correlations between serum Reg 1a and other factors were presented by Spearman's correlation coefficient and partial correlation analysis. Multivariate logistic regression analysis was utilized to identify the independent risk factors for chronic renal dysfunction and the progress in CKD. Draw the receiver operating characteristic curve (ROC curve) and calculate the area under the curve (AUC) to analyze the effectiveness of the individual serum Reg 1a. Statistical analyses were conducted using SPSS 20.0 software, Med-Calc statistical software. Results A total of 640 participants were enrolled in this study including non-CKD subjects (n = 240) and patients with CKD (n = 400). Compared with non-CKD group, participants in CKD group had higher level of serum reg 1a (188.2 [66.7∼387.6] ng/ml vs 23.8 [14.7∼35.1] ng/ml, P<0.001). Serum reg 1a level elevated with increasing grades of CKD. Serum reg 1a was negatively correlated with eGFR and positively associated with age, hypertension, Scr, BUN, UA and UACR (P<0.001). In multiple logistic regression analysis, serum reg 1a was one of independent risk factors to predict renal dysfunction (OR = 1.010 [1.003, 1.018], P = 0.008). The AUC for serum reg 1a to predict CKD was 0.889 [0.862, 0.913], and the AUC for serum reg 1a to screen the eGFR lower than 30 ml/min/1.73 m2 in CKD groups was 0.919 [0.888, 0.944]. Subgroup analysis showed that serum reg 1a is an independent risk factor to predict early progress of UACR (OR = 1.012 [1.002, 1.022], P = 0.016) in CKD patients. Conclusion The study provides clinical evidence that serum reg 1a may a meaningful biomarker of early kidney impairment and a useful supplementary factor in the progression of CKD.

Relationship Between Soluble CD146 and Renal Function in Patients with Chronic Kidney Disease

Predicting Cardiovascular Mortality in Chronic Kidney Disease (CKD) Patients.

High Serum Level of the Soluble CD30 Identifies Chinese Kidney Transplant Recipients at High Risk of Unfavorable Outcome

Plasma Soluble CD146 as a Potential Diagnostic Marker of Acute Rejection in Kidney Transplantation

Relations Between Markers of Renal Function, Coronary Risk Factors and the Occurrence and Severity of Coronary Artery Disease

Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease

Urinary soluble CD90 predicts renal prognosis in patients with diabetic kidney disease

[Influence of Pre-Transplant Serum Level of Soluble CD30 on the Long-Term Survival Rates of Kidney Transplant Recipients and Grafts].

Facilitation by imidazole of the aqueous flare response toα-melanocyte stimulating hormone

The relationship between serum levels of LOX-1, hs-cTnT, NGAL, and renal function, and their diagnostic value in patients with chronic kidney disease: a retrospective study

Relationship Between Soluble Receptor of Advanced Glycation End Product and Carotid Atherosclerosis in Patients under Hemodialysis

Acute rejection episodic outcomes resulted from pre-transplant serum level of the soluble CD30 in kidney transplant recipients

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status

Interaction of Soluble CXC Ligand 16 and Cardiac Injury Markers in Hemodialysis Patients

Soluble Urokinase-Type Plasminogen Activator Receptor and Incident End-Stage Renal Disease in Chinese Patients with Chronic Kidney Disease.

Soluble CD14 and Osteoprotegerin Associate with Ankle-Brachial Index as a Measure of Arterial Stiffness in Patients with Mild-to-Moderate Chronic Kidney Disease in a Five-Year Prospective Study

Association of CD30 genetic polymorphism with chronic renal failure and acute rejection reaction after renal transplantation

#4948 ROLE OF REGENERATING PROTEIN 1A IN THE PROGRESSION OF CHRONIC KIDNEY DISEASE

Association of Kidney Size with Renal Function in Community Patients with Chronic Kidney Diseases

Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease

Soluble Vascular Cell Adhesion Molecule-1 Is Associated With Disease Activity in Adult-Onset Minimal Change Disease.